Intraureteral Lidocaine for Post-Ureteroscopy Pain
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Ureteroscopy (URS) is minimally invasive procedure for management of renal stones. URS is
often involves concomitant of an indwelling ureteral stents. Placements of these stents
include pain, bladder irritability, infection, migration, encrustation and stones.
Pain is one of most significant problem of ureteral stents. There are no satisfactory
measures to deal with this problem. A novel approach to manage the pain is to load a drug
onto ureteral stent and deliver the drug into the urinary tract at controlled release rate.
Lidocaine has been proven to be effective for management of the pain associated with
interstitial cystitis. This agent has the potential for management of post-URS pain.